Forecast to Publish a Notice of Funding Opportunity (NOFO) for NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
This grant will fund research hubs to lead and manage multi-institutional cancer control clinical trials in community settings, aiming to improve cancer prevention, care delivery, and address health disparities.
Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 | November 2026 | November 2025
Funding Amounts: Estimated total program funding: $60,000,000–$74,500,000 | Expected number of awards: 7 | Multi-year cooperative agreements
Summary: Supports multi-institutional cancer control, prevention, and care delivery research through community-based research hubs (Research Bases) in the NCI Community Oncology Research Program (NCORP).
Key Information: This opportunity is forecasted; all deadlines are projected and subject to change.
Description
This funding opportunity supports the establishment and operation of NCORP Research Bases, which serve as research hubs for the National Cancer Institute (NCI) Community Oncology Research Program. NCORP is a national network designed to enhance the generalizability and dissemination of clinical trial results by engaging diverse cancer patient populations and organizations in rigorous studies focused on cancer control, prevention, treatment, and care delivery.
Research Bases are responsible for:
- Developing, implementing, and analyzing multi-institutional cancer control, prevention, and care delivery clinical research, including quality-of-life studies.
- Providing scientific and statistical leadership, study operations, and data management.
- Ensuring compliance with regulatory and participant protection requirements.
- Supporting affiliated Community Sites and Academic Community Sites with training, quality assurance, and operational guidance.
- Integrating health disparities research across all focus areas.
The research scope includes:
- Area 1: Cancer Control Research (required)
- Area 2: Cancer Prevention Research (optional)
- Area 3: Cancer Care Delivery Research (optional)
Institutions applying must have comprehensive expertise in cancer clinical research, such as NCI-designated Cancer Centers, healthcare research organizations, or cancer foundations associated with NCI's National Clinical Trials Network.
